Statistics for A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America
Total visits
| views | |
|---|---|
| A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America | 253 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Raje_2018_cost-effectiveness.pdf | 445 |
| java.util.UUID:3444e723-ba03-454d-af92-f6ce6eaf716a | 80 |
| java.util.UUID:d53b340e-1249-4dad-8dfe-9ce1d4cbc59f | 12 |
| java.util.UUID:8ec90e3d-15d5-4052-8ebf-081335953681 | 9 |
Top country views
| views | |
|---|---|
| United States | 196 |
| Germany | 10 |
| Sweden | 7 |
| Ukraine | 6 |
| India | 4 |
| Russia | 4 |
| Canada | 3 |
| China | 2 |
| Spain | 1 |
| United Kingdom | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 51 |
| Fairfield | 38 |
| Houston | 11 |
| White Plains | 9 |
| Cambridge | 7 |
| Jacksonville | 7 |
| Kiez | 7 |
| Stockholm | 7 |
| Kiev | 6 |
| San Francisco | 5 |
| Ann Arbor | 4 |
| Washington | 4 |
| Dearborn | 3 |
| Gunzenhausen | 3 |
| New Delhi | 3 |
| Toronto | 3 |
| Baltimore | 2 |
| Kansas City | 2 |
| Miami | 2 |
| Ashburn | 1 |
| Bartlesville | 1 |
| Beijing | 1 |
| Black Mountain | 1 |
| Brooklyn | 1 |
| Costa Mesa | 1 |
| Lake Mary | 1 |
| Madrid | 1 |
| Moscow | 1 |
| New York | 1 |
| Philadelphia | 1 |
| Saint Petersburg | 1 |
| Scottsdale | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Sholinganallur | 1 |
| West Lafayette | 1 |